Promotion of transition metal-induced reactive oxygen species formation by β-amyloid

Brain Research

Volumn 799, Issue 1, 1998, Pages 91-96

  Bondy, Stephen C ^a   Guo Ross, Shirley X ^a   Truong, Anh T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aluminum; Amyloid; Iron; Reactive oxygen species; Transition metal

Indexed keywords

AMYLOID BETA PROTEIN; METAL; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; MALE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT;

ALUM COMPOUNDS; AMYLOID BETA-PROTEIN; ANIMALS; COPPER SULFATE; DRUG SYNERGISM; FERROUS COMPOUNDS; GLUTATHIONE; MALE; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 0032514165     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00461-2     Document Type: Article

References (52)

1. Armstrong R.A., Winsper S.J., Blair J.A. Aluminum and Alzheimer's disease: review of possible pathogenic mechanisms. Dementia. 7:1996;1-9.
2. Bass D.A., Parce J.W., Dechatelet L.R., Sjeda P., Seeds M.C., Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded dose response to membrane stimulation. J. Immunol. 130:1983;1910-1917.
3. Benzi G., Moretti A. Are reactive oxygen species involved in Alzheimer's disease? Neurobiol. Aging. 16:1995;661-674.
4. Bjertness E., Candy J.M., Torvik A., Ince P., MacArthur F., Taylor G.A., Johansen S.W., Alexander J., Gronnesby J.K., Bakketeig L.S., Edwardson J.A. Content of brain aluminum is not elevated in Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 10:1996;171-174.
5. Bondy S.C., Kirstein S. The promotion of iron-induced generation of reactive oxygen species in nerve tissue by aluminum. Mol. Chem. Neuropath. 27:1996;185-194.
6. Bondy S.C., Guo-Ross S.X., Pien J. Mechanisms underlying the aluminum-induced potentiation of the pro-oxidant properties of transition metals. Neurotoxicology. 19:1998;65-72.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye-binding. Anal. Biochem. 72:1976;248-254.
8. Cafe C., Torri C., Bertorelli L., Angeretti N., Lucca E., Forloni G., Marzatico F. Oxidative stress after acute and chronic application of β-amyloid fragment 25-35 in cortical cultures. Neurosci. Lett. 203:1996;61-65.
9. Chong Y.H., Suh Y.H. Aggregation of β-amyloid precursor proteins by aluminum in vitro. Brain Res. 670:1995;137-141.
10. Connor J.R., Snyder B.S., Beard J.L., Fine R.E., Mufson E.J. Regional distribution of iron and iron regulatory proteins in the brain aging and Alzheimer's disease. J. Neurosci. Res. 31:1992;327-335.
11. Daniel C.N., Mao Y., Saffiotti U. Oxidative damage by crystalline silica. Free Radic. Biol. Med. 14:1993;463-472.
12. Donaldson K., Beswick P.H., Gilmour P.S. Free radical activity associated with the surface of particles: a unifying hypothesis in determining biological activity. Toxicol. Lett. 88:1996;293-298.
13. Edwardson J.A., Candy J.M., Ince P.G., McArthur F., Morris C.M., Oakely A.E., Taylor G.A., Bjertness E. Aluminum accumulation, beta-amyloid deposition, and neurofibrillary changes in the central nervous system. Ciba Found. Symp. 169:1992;165-179.
14. Felix C.C., Hyde J.S., Sarna T., Sealy R.C. Interactions of melanin with metal ions. Electron spin resonance evidence for chelate complexes of metal ions with free radicals. J. Am. Chem. Soc. 100:1978;3922-3926.
15. Fubini B., Mollo L., Giamello E. Free radical generation at the solid/liquid interface in iron-containing minerals. Free Radic. Res. 23:1995;593-614.
16. Gerlach M., Ben-Schacher D., Riederer P., Youdim M.B.H. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63:1994;793-807.
17. Good P.F., Perl D.P., Bierer L.M., Schmiedler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's diseases: a laser microprobe (LAMMA) study. Ann. Neurol. 31:1992;286-292.
18. Gutteridge J.M.C., Quinlan G.J., Clark I., Halliwell B. Aluminum salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochim. Biophys. Acta. 835:1985;441-447.
19. Halliwell B. Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action? Free Radic. Biol. Med. 7:1989;645-651.
20. Harman D. Free radical theory of aging: Alzheimer's disease pathogenesis. Age. 18:1995;97-119.
21. Harris M.E., Carney J.M., Cole P.S., Hensley K., Howard B.J., Martin L., Bummer P., Wang Y., Pedigo N.W., Butterfield D.A. β-amyloid peptide-derived, oxygen dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease. NeuroReport. 6:1995;1875-1879.
22. Hayn M., Kremser K., Singewald N., Cairns N., Nemethova M., Lubec B., Lubec L. Evidence against involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease. Life Sci. 59:1996;537-544.
23. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., Butterfield D.A. A model for beta-amyloid aggregation and neurotoxicity based on a free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 91:1994;3270-3274.
24. Hensley K., Hall M., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S.P., Wu J.F., Carney J.M., Lovell M., Butterfield D.A. Brain regional correspondence between Alzheimer's disease histopathologically and biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156.
25. Huang X., Atwood C.S., Goldstein L.E., Hartshorn M.A., Moir R.D., Multhaup G., Tanzi R.E., Bush A.I. Alzheimer Aβ peptides simultaneously reduce metals and produce reactive oxygen species. Abstr. Soc. Neurosci. 23:1997;1883.
26. Ii M., Sunamoto M., Ohnishi K., Ichmori Y. β-amyloid protein dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res. 720:1996;93-100.
27. Klebanoff S.J., Waltersdorph A.Am., Michel B.R., Rosen H. Oxygen-based free radical generation by ferrous ions and deferoxamine. J. Biol. Chem. 264:1989;19765-19771.
28. LeBel C.P., Bondy S.C. Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes. Neurochem. Int. 17:1990;435-440.
29. Lison D., Carbonelle P., Mollo L., Lauwerys R., Fubini B. Physicochemical mechanism of the interaction between cobalt metal and carbide particles to generate toxic activated oxygen species. Chem. Res. Toxicol. 6:1995;600-606.
30. Lockhart B.P., Benicourt C., Junien J.L., Privat A. Inhibitors of free radical formation fail to attenuate direct β-amyloid peptide mediated neurotoxicity in rat hippocampal cultures. J. Neurosci. Res. 39:1994;494-505.
31. Loeffler D.A., Connor J.R., Juneau P.L., Snyder B.S., Kanaly L., De Maggio A.J., Nguyen H., Brickman C.M., Le Witt P.A. Transferrin and iron in normal, Alzheimer's disease and Parkinson's disease brain regions. J. Neurochem. 65:1995;710-716.
32. Manelli A.M., Puttfarken P.S. β-amyloid-induced toxicity in rat hippocampus cells: in vitro evidence for the involvement of free radicals. Brain Res. Bull. 38:1995;569-576.
33. Mantyh P.W., Ghilardi J.R., Rogers S., DeMaster E., Allen C.J., Stimson E.R., Maggio J.E. Aluminum, iron and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J. Neurochem. 61:1993;1171-1174.
34. Maples K.J., Johnson N.F. Fiber-induced hydroxyl radical formation: correlation with mesothelioma in rats and humans. Carcinogenesis. 11:1992;2035-2039.
35. McLaughlan D.R.C., Begeron C., Smith J.E., Boomer D., Rifot S.L. Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology. 46:1996;401-405.
36. Multhaup G., Schlicksupp A., Hesse L., Beher D., Ruppert T., Masters C.L., Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I). Science. 271:1996;1406-1409.
37. Oteiza P.I. A mechanism for the stimulatory effect of aluminum on iron induced lipid peroxidation. Arch. Biochem. Biophys. 308:1994;374-379.
38. Pappola M.A., Omar R.A., Kim K.S., Robakis M.K. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease. Am. J. Pathol. 140:1992;621-628.
39. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. In vitro aging of β-amyloid protein, peptide aggregation and neurotoxicity. Brain Res. 563:1992;311-314.
40. Pike C.J., Ramazan-Arab N., Cotman C.W. β-amyloid neurotoxicity in vitro: evidence of oxidative stress but not protection by antioxidants. Brain Res. 69:1997;1601-1611.
41. 3+ toxicity. Biochim. Biophys. Acta. 964:1988;137-145.
42. Schubert D., Chevion M. The role of iron in β amyloid toxicity. Biochem. Biophys. Res. Commun. 216:1995;702-707.
43. Schubert D., Behl C., Lesley R., Brack A., Dargusch R., Sagara Y., Kimura H. Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. U.S.A. 92:1995;1989-1993.
44. Shrieve D.C., Bump E.A., Rice G.C. Heterogeneity of cellular glutathione among cells derived from a murine fibrosarcoma or a human renal cell carcinoma detected by flow cytometric analysis. Biochem. J. 263:1988;14107-14114.
45. Simeonova P.P., Luster M. Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-α response from alveolar macrophages. Am. J. Respir. Cell. Mol. Biol. 12:1995;676-683.
46. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 88:1991;10540-10548.
47. Smith M.A., Rudnicka-Nawrot M., Richey P.L., Prapotnik D., Mulvihill P., Miller C.A., Sayre L.M., Perry G. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J. Neurochem. 64:1995;2660-2666.
48. Smith M.A., Harris P.L.R., Sayre L.M., Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U.S.A. 94:1997;9866-9868.
49. Tokutake S., Nagase H., Morisaki S., Oyanagi S. Aluminum detected in senile plaques and neurofibrillary tangles, is contained in lipofuscin granules with silicon probably as aluminosilicate. Neurosci. Lett. 185:1995;99-102.
50. Wahba Z.Z., Murray W.J., Stohs S.J. Desferrioxamine-induced alterations in hepatic iron distribution, DNA damage and lipid peroxidation in control and 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats. J. Appl. Toxicol. 10:1990;119-124.
51. Walter M.F., Mason P.E., Mason R.P. Alzheimer's disease amyloid β peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions. Biochem. Biophys. Res. Commun. 233:1997;760-764.
52. Zhou Y., Richardson R.S., Mombourquette M.J., Weil J.A. Free radical and aluminum formation in autopsy samples of Alzheimer and control cortex. Neurosci. Lett. 195:1995;89-92.